arrow
M

Megan Lawrence

southampton clinical trials unit
H指数:9
被引数:293

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing a facilitated social network intervention for health outcomes in lonely and socially isolated people: the pragmatic; cluster-randomized PALS trial

评估一项促进性社交网络干预措施对孤独及社会孤立人群健康结局的影响:一项实用性、整群随机PALS试验

2026-04-030
OAAI
Correction: Miglustat as a Treatment for Adults with Tangier Disease Neuropathy: The MUSTANG N‑of‑1 Trial with 21 months Clinical Observation

更正:Miglustat作为治疗Tangier病神经病变成年患者的方案:一项为期21个月临床观察的MUSTANG N-of-1试验

2026-03-120
OAAI
Miglustat as a Treatment for Adults with Tangier Disease Neuropathy: The MUSTANG N-of-1 Trial with 21 months Clinical Observation

米格lustat作为治疗Tangier病患者神经病变的药物:为期21个月的MUSTANG N-of-1临床试验临床观察

2025-11-100
OAAI
Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trial
2025-10-310
OA
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT

螺内酯治疗女性面部顽固性痤疮的临床和成本效益: SAFA双盲RCT

2024-09-011
OA
Digital intervention (Renewed) to support symptom management, wellbeing, and quality of life among cancer survivors in primary care: a randomised controlled trial

数字干预 (更新) 以支持初级保健中癌症幸存者的症状管理,健康和生活质量: 一项随机对照试验

2023-12-201
OAAI
Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trial

iWHELD数字以人为中心的护理计划对新型冠状病毒肺炎大流行期间居住在疗养院的痴呆症患者的生活质量,躁动和精神药物的影响: 一项随机对照试验

2023-12-201
OA
Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial

评估尿路鳞状细胞癌 (AURORA) 患者的atezolizumab: 单臂,开放标签,多中心,II期临床试验的研究方案

2023-09-190
OAAI
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial

螺内酯对英格兰和威尔士女性寻常痤疮 (SAFA) 的有效性: 实用,多中心,3期,双盲,随机对照试验

2023-05-1619
OAAI
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2
2021-11-1314
OAAI